Innate Pharma S.A. (NASDAQ:IPHA) Q4 2024 Earnings Call Transcript March 27, 2025
Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 EPS, expectations were $-0.26681.
Operator: Hello, and welcome to the Innate Pharma Full Year 2024 Financial Results and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the...
